ICR researchers highlight industry interactions
Watch our featured videos:
Developing therapeutic ultrasound
Professor Gail ter Haar's team are working with industrial partners to help advance their research and get new techniques to patients faster.
Access to state-of-the-art sequencing for industry partners
Staff at the Tumour Profiling Unit support researchers to accelerate progress towards precision therapies.
Industry partnerships in breast cancer research
Dr Rachael Natrajan is looking to form partnerships with industry.⠀⠀⠀⠀⠀
First-in-human phase I trials in collaboration with industry
Professor Banerji plays a key role bridging pre-clinical and clinical drug development, designing and conducting first-in-human phase I trials of new cancer drugs.
Technology development at the cutting edge of fundamental biology
Professor Pines leads the fundamental biology research at the top-ranked higher education institute for Biological Sciences in the UK.
Drug development and clinical trials
Professor Harrington has a track record of successful industry partnerships.
Watch more enterprise videos:
Working with pharmaceutical companies
Dr Marco Gerlinger's Translational Oncogenomics Team are keen to develop new partnerships to continue their work, and to access drugs that could reverse the resistance mechanisms that the team has identified so far.
New partnerships in cancer epigenetics
Sharing experience with industry partners
Our Molecular and Systems Oncology Team, led by Dr Paul Huang, is keen to collaborate with industry partners on a number of projects on biochemistry, computational modelling, molecular pathology and proteomics.
Collaborating with commercial partners
Our Systems and Precision Cancer Medicine team, led by Dr Anguraj Sadanandam, is investigating ways to stratify tumours based on their genetic and clinical diversity.
The benefits of partnering with industry
Our Molecular Addictions team, led by Dr Igor Vivanco, is working on a variety of projects that could be developed in collaboration with commercial partners.
Exploring new opportunities for collaborative working
Professor Uwe Oelfke, Deputy Head of the Division of Radiotherapy and Imaging, is keen to explore new opportunities for collaborative working with industry.